Ergomed Plc, a listed UK clinical-trial services organisation, is raising between £9 and £13 million with a share placement that will help finance the takeover of Haemostatix Ltd, which is developing products for inducing rapid blood clotting. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals